在基因治疗的前沿骑车。

Q1 Medicine

Human Gene Therapy Clinical Development Pub Date : 2019-06-01 DOI:10.1089/humc.2019.29046.int

James M Wilson

引用次数: 1

摘要

编者按:帕特里克·瓦伦斯爵士是英国政府首席科学顾问。在这里，他讨论了他从学术界到工业界再到政府的道路，并反思了早期关键的对话，这些对话对基因治疗研究的成功临床开发起到了重要作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Cycling at the Frontiers of Gene Therapy.

Editor's note: Sir Patrick Vallance is Government Chief Scientific Adviser in the United Kingdom. Here he discusses his path from academia to industry to government, and he reflects on the crucial early conversations that were instrumental in positioning gene therapy research for successful clinical development.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Human Gene Therapy Clinical Development CRITICAL CARE MEDICINEMEDICINE, RESEARCH &-MEDICINE, RESEARCH & EXPERIMENTAL

CiteScore

7.20

自引率

0.00%

发文量

期刊介绍： Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes important advances in DNA, RNA, cell and immune therapies, validating the latest advances in research and new technologies.